Company
Ultragenyx Pharmaceutical Inc.
RARE · CIK 0001515673
Sale of 7,066 shares at $15.27 per share.
Reporting Person Horn Howard · Officer Title Chief Financial Officer · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001193125-26-425032 · filed 2026-10-19 · View filing →
Sale of 1,283 shares at $13.57 per share.
Reporting Person Huizenga Theodore Alan · Officer Title SVP, Chief Accounting Officer · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001193125-26-392233 · filed 2026-09-15 · View filing →
Sale of 161 shares at $13.99 per share.
Reporting Person Huizenga Theodore Alan · Officer Title SVP, Chief Accounting Officer · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001193125-26-384878 · filed 2026-09-08 · View filing →